Abstract
Objective:
To characterize the obstetrical management and outcomes in a series of women with a history of Kawasaki disease (KD) in childhood
Design:
Retrospective case series
Setting:
Tertiary healthcare setting in the United States
Population:
Women with a history of KD in childhood
Methods:
Subjects completed a detailed health questionnaire and participated in research imaging studies as part of the San Diego Adult KD Collaborative Study.
Main outcome measures:
Obstetrical management; complications during pregnancy and delivery; infant outcomes.
Results:
Ten women with a history of KD in childhood carried a total of 21 pregnancies to term. There were no cardiovascular complications during labor and delivery despite important cardiovascular abnormalities in four of the ten subjects. Pregnancy was complicated by preeclampsia and the post-partum course was complicated by hemorrhage in one subject each. Two of the 21 progeny subsequently developed KD.
Conclusions:
Women with important cardiovascular sequelae from KD in childhood should be managed by a team that includes both a maternal-fetal medicine specialist and a cardiologist. Pre-pregnancy counseling should include delineation of the woman’s current functional and structural cardiovascular status and appropriate adjustment of medications, but excellent outcomes are possible with appropriate care. Review of the English and Japanese literature on KD and pregnancy revealed the occurrence of myocardial infarction during pregnancy in women with missed KD and aneurysms that were not diagnosed until their acute event. Our study highlights the need for counseling regarding the increased genetic risk of KD in offspring born to these mothers.
Keywords: Kawasaki disease, pregnancy, coronary artery aneurysms, vasculitis, anticoagulation
Introduction
A growing number of women with a history of Kawasaki Disease (KD) are reaching child-bearing age and little information is available to guide obstetrical care and management of this patient population. KD, a self-limited vasculitis affecting the coronary arteries, and the most common cause of acquired heart disease in children, was first recognized in Japan following World War II and is being diagnosed with increasing frequency among children in Asia, the United States and Western Europe.1-4 System dynamic models suggest that by 2030, one in every 1,600 adults in the US will have suffered from KD.5 KD is diagnosed by a constellation of clinical signs with supportive laboratory data suggesting high levels of inflammation. The clinical signs include the abrupt onset of high fever, accompanied by four of the five following criteria: polymorphous exanthem, oral changes including pharyngeal erythema, cracked fissured lips, and a strawberry tongue, bilateral conjunctival injection, cervical lymphadenopathy, and extremity changes that include edema, palm and sole erythema, and periungual desquamation in the convalescent phase. 6 Without treatment, 25% of children will develop coronary artery aneurysms that are associated with a risk of thrombosis and myocardial infarction.7 Over time, most coronary artery aneurysms develop thickened walls with heavy calcification and rupture is virtually never seen.8 Because the etiology of KD is unknown and the diagnosis is based solely on clinical criteria, many cases are missed and may present in adulthood with myocardial infarction, congestive heart failure, or sudden death.9-11 Timely treatment with high dose intravenous immunoglobulin (IVIG) and aspirin reduces the risk of aneurysms to 5%.12 Long-term outcome for adults with a history of KD in childhood is only now being studied.9 Recently, coronary calcium scoring by non-contrast computed tomography (CT calcium score) has been used for the detection of silent coronary artery damage decades after KD.13 Adults with cardiovascular complications resulting from KD may require interventions including angioplasty with stent placement, coronary artery bypass grafting (CABG), or cardiac transplantation, and may require treatment with a variety of medications including antiplatelet agents, systemic anticoagulation, statins, and angiotensin receptor blockers.9 This case series encompasses the spectrum of cardiovascular abnormalities that the obstetrician may encounter in pregnant women with a history of KD in childhood and provides perspective on issues to be considered in the management of these women during pregnancy and delivery.
Methods
We administered a general health questionnaire and performed interviews and physical examinations on all female subjects who had been pregnant and were enrolled in the San Diego Adult Kawasaki Disease Collaborative Study at the Kawasaki Disease Research Center at UCSD. Of the 130 enrolled subjects, 58 were women and ten had had at least one pregnancy. Data collection included demographic information, details of the initial history of KD, cardiovascular complications, medications, therapeutic interventions, cardiovascular risk factors, obstetrical history, and pregnancy outcome. This protocol was approved by the Institutional Review Board at UCSD and all subjects gave their written informed consent. We completed a comprehensive review of the current literature in English and in Japanese using PubMed and Japan Medical Abstracts Society with “Kawasaki Disease” and “pregnancy” as the search terms.
Results
The cardiovascular and obstetrical outcomes of ten women with a history of KD in childhood were reviewed. Four of the ten women had important cardiovascular sequelae from their KD including coronary artery aneurysms (4 subjects), myocardial infarction (2 subjects), and coronary artery bypass grafting (3 subjects) (Table 1). In three of the four women, these events occurred prior to their first pregnancy. In the fourth woman (Table 1, subject 10), who suffered four myocardial infarctions, two of these events occurred prior to her first pregnancy and the subsequent events were not temporally related to her subsequent pregnancy. Two of these four women were advised either not to become pregnant or to terminate the pregnancy in the first trimester by physicians who were unfamiliar with KD. Of the three subjects with cardiovascular sequelae who had assessment of their coronary artery calcium by computed tomography (CT), all had evidence of calcium deposition in the arterial wall (Table 1) (Figure 1). During their eight pregnancies, all four women with cardiovascular sequelae of KD were treated with aspirin, while three of the four women were also treated with enoxaparin (Table 2). None experienced cardiovascular complications during pregnancy. Two subjects had elective cesarean sections (C-sections) because of concerns for potential cardiovascular complications during labor. Of the five infants delivered vaginally, one required forceps-assisted delivery. The only obstetrical complication amongst these four women with aneurysms was post-partum hemorrhage requiring blood transfusion following C-section in one. Of note, this patient was restarted on heparin immediately post-partum, which may have contributed to the consequent hemorrhage. Of the eight infants born to these four mothers, all were carried to term and were healthy; one had trisomy 21.
Table 1.
Demographic and clinical characteristics and cardiovascular complications in women with a history of Kawasaki disease in childhood.
| Subject | Age at onset of KD (years) |
Ethnicity | Treatment for acute KD |
CA Status |
Complications | CT calcium volume score (mm3) |
|---|---|---|---|---|---|---|
| 1 | 0.5 | Caucasian | Not treated, given aspirin |
Nl | None | 0 |
| 2 | 1.5 | Korean | Treated with steroids |
Nl | None | 0 |
| 3 | 2 | Hispanic | Treated with IVIG |
Nl | None | 0 |
| 4 | 5 | Hispanic | Treated with IVIG |
Nl | None | 0 |
| 5 | 5 | Caucasian | Not treated (missed KD) |
+CAA | CABG(18 yrs) | NA |
| 6 | 5 | Caucasian | Not treated (missed KD) |
+CAA | CABG (12 yrs) | 2123 |
| 7 | 6 | Caucasian | Treated, specifics unknown |
Nl | None | 0 |
| 8 | 12 | AA/Caucasian | Not treated (missed KD) |
+CAA | MI (24 yrs), CABG (24 yrs) |
8218 |
| 9 | 12 | Caucasian | Late treatment |
Nl | None | NA |
| 10 | 15 | Caucasian | Late treatment |
+CAA | MI x4 (19, 20, 29, and 33 yrs) |
234 |
Abbrv. KD: Kawasaki disease; CA: coronary artery; CT: computed tomography; IVIG: intravenous immunoglobulin; Nl: normal; CAA: coronary artery aneurysms; CABG: coronary artery bypass grafting; NA: not available MI: myocardial infarction.
Computed tomography coronary artery calcium scan of a 44 year old woman with a history of Kawasaki Disease at 13 years of age, giant coronary artery aneurysms and a scan demonstrating severe coronary calcification of the left anterior descending artery (black arrow).
Table 2.
Obstetrical management and outcome of women with history of Kawasaki Disease in childhood
| Subject | Gravidity/ parity |
Age at first pregnancy |
Medications during pregnancy |
Delivery | Complications During Pregnancy/ Delivery |
|---|---|---|---|---|---|
| 1 | G2P2002** | 27 | None | NVD | Pre-eclampsia with first pregnancy |
| 2 | G4P4004 | 31 | None | NVD | Premature labor @ 24 wks gestation with first pregnancy |
| 3 | G2P2002 | 18 | None | NVD | None |
| 4 | G4P2022 | 28 | None | NVD | None |
| 5* | G5P4014 | unknown | aspirin, enoxaparin |
NVD | None |
| 6* | G2P1011 | 32 | aspirin enoxaparin, |
Forceps required, VD |
None |
| 7 | G3P2012 | 29 | None | 1 NVD, 1 C-section |
None |
| 8* | G1P1001 | 41 | aspirin | C-section | None |
| 9 | G2P1011 | 28 | None | NVD | None |
| 10* | G2P2002 | 32 | aspirin, enoxaparin |
C-section | Post-partum hemorrhage requiring blood transfusion with 2nd pregnancy |
Number of pregnancies with the following outcomes: (Term, premature, aborted, live birth)
Patients with significant cardiovascular abnormalities
Abbr. NVD: normal vaginal delivery, C-section: cesarean section
Of the six women with no detectable cardiovascular sequelae from KD, no cardiovascular medications were prescribed during pregnancy and healthy infants were delivered by spontaneous vaginal delivery in five women and by C-section in one woman. One patient had premature labor at 24 weeks but carried her infant to term; another patient had pre-eclampsia with a normal vaginal delivery at term.
Of the 21 infants delivered to the ten mothers in this series, two developed KD at ages 2 and 5 months. Both infants were treated with IVIG and had normal coronary artery internal dimensions as measured by echocardiography. One infant developed mild aortic root dilatation that subsequently resolved.
Discussion
Main Findings
In our series of ten women with a history of KD in childhood, only one experienced an obstetrical complication of post-partum hemorrhage that was possibly related to premature reinstitution of heparin therapy after delivery. C-section was recommended for two women solely because of concerns for potential cardiovascular complications during labor. There is currently no systematically collected data on which to base recommendations for the management of pregnancy and delivery in this patient population. However, the outcomes with routine obstetrical management appear to be favorable.
Strengths and Limitations
We recognize several strengths and limitations to our work. This is the first reported series of women with a history of KD in childhood whose cardiovascular status was systematically evaluated as part of a prospective study of outcomes in young adults after KD. However, the details of the patients’ obstetrical care were obtained from patients and therefore all of the caveats and potential biases of a retrospective study apply. In addition, our small sample size limits the strength of the conclusions that can be drawn.
Interpretation
A range of cardiovascular abnormalities can be encountered in young adults following KD in childhood. These may include coronary artery aneurysms with varying degrees of altered blood flow, coronary artery stenoses, myocardial ischemia, myocardial fibrosis, congestive heart failure, and valvular abnormalities including stenosis and incompetence.14-17 Women with coronary artery aneurysms may have experienced myocardial infarction or undergone interventions including percutaneous coronary intervention with or without stenting, coronary bypass surgery, or cardiac transplantation. All of these cardiovascular complications of KD pose potential risks to the mother during pregnancy, labor, and delivery. In addition, medications used to manage complications of KD may pose a risk to the fetus and must be assessed during pre-pregnancy screening. Most patients with aneurysms are treated with antiplatelet agents (aspirin or thienopyridines) and current recommendations are to treat patients with giant coronary artery aneurysms (defined as >8mm in diameter) with warfarin because of the high risk of thrombosis due to altered hemodynamics within the aneurysm.6,18,19
Japan is the country of highest incidence of KD, although all racial groups may be affected. A comprehensive review of the Japanese literature patients yielded eleven reports that detailed the management, delivery method, and outcomes in 52 Japanese women with a history of KD (Table 3).20-30 All but two women had coronary artery aneurysms and three had undergone CABG. Of the 72 deliveries, 29 (40.3%) were C-sections. Obstetrical complications were reported in seven (9.7%) deliveries including premature rupture of membranes, pre-term labor, and post-partum hemorrhage. Cardiovascular complications were reported in five (9.6%) women and included reduced ejection fraction in one, and chest pain, low oxygen saturation, premature ventricular beats, and bradycardia among the remaining four women. Of the 72 infants, 63 (87.5%) were delivered at term and were healthy; two infants were delivered prematurely at 33 weeks by C-section due to maternal distress, described as chest pain, bradycardia, and low oxygen saturation. Five additional infants were born prematurely. Two additional infants had congenital abnormalities consisting of ventricular septal defect and agenesis of the corpus callosum. The variation in obstetrical management in these women underscores the need for prospective studies that can better define the risks in this patient population and lead to the development of consistent management guidelines.
Table 3.
Obstetrical management and outcome of 81 pregnancies in 55 women with a history of Kawasaki disease published in the English and Japanese language literature.
| Author, year |
Study design | Sample size |
Coronary artery status of subjects |
Mode of delivery |
Cardiac complications |
Obstetrical Complications |
Outcome |
|---|---|---|---|---|---|---|---|
| Nolan, 1990 | Case report | 1 | Hx of KD- compatible illness in childhood, CAA |
NVD | MI at 38 wks; CAA by echo- cardiogram |
None | 38 wks, healthy |
| Alam, 1995 | Case report | 1 | Giant CAA with occluded RCA |
C-section | None | None | 40 wks, healthy |
| Kurioka, 1996 (In Japanese) |
Case report | 1 | Hx of KD- compatible illness in childhood, CAA of LMCA and stenosis of RCA |
C-section | None | None | 41 wks, healthy |
| Arakawa, 1997 |
Case report | 1 | CAA | C-section | None | None | 38 wks, healthy |
| Tsuda, H. 1997 (In Japanese) |
Case report | G1P1 | Giant CAA with stenosis |
C-section | 26wks. EF 47.1% |
None | 38 wks, healthy |
| Iino, 1997 (In Japanese) |
Case report | G1P1 | CAA and occlusion with collaterals |
C-section | None | 30wks. premature labor 37wks. PROM |
37 wks, healthy |
| Hayakawa, 1998 |
Case report | 1 | S/P CABG | NVD | None | None | Term, healthy |
| Shear, 1999 | Case report | 1 | CAA | NVD | None | None | 38 wks, healthy |
| Tsuda, E. 1999 (In Japanese) |
Case report | G1P1 | CAA with stenosis and calcification |
C-section (33w6d) |
Chest pain, PVC, bradycardia, low oxygen saturation |
Premature birth |
33 wks, 1855g, Apgar 6/7/7 |
| McAndrew, 2000 |
Case report | G5P5 | KD hx unknown; CAA |
4 NVD 1 C- section |
Cardiac arrest at 20 wks. gestation; CAA at angiography |
None | Term infants, healthy |
| Tatsumi, 2001 (In Japanese) |
Case report | 4 | CAA, CABG | NVD | None | None | 37 wks, healthy |
| CAA, CABG | NVD | 32wks. PVC | None | 39 wks, healthy | |||
| Giant CAA | C-section (33w6d) |
Dyspnea, Low oxygen saturation |
None | 33 wks, healthy | |||
| Giant CAA | NVD | Occasional PVC, 5min fetal bradycardia before delivery |
None | 39 wks, healthy | |||
| Tsuda, E. 2005 |
Retrospective case series |
10 subjects 13 deliveries |
All with CAA | 10 NVD 3 C- sections |
None | 1 PROM with vaginal hemorrhage |
12 term infants 1 premature infant |
| Tsuda, E. 2006 |
Questionnaire completed by physician |
30 women 46 deliveries |
All with CAA | 27 NVD 19 C- sections |
None | 1 PROM 1 post-partum hemorrhage on heparin |
40 term infants: 1 VSD, 1 agenesis of the corpus callosum, 4 premature infants |
| Hibbard, 2007 |
Case report | G2P2 | CAA | NVD | None | G1 pre- eclampsia G2 mild hypertension |
35 wks 37 wks |
| Kobara, 2011 (In Japanese) |
Case report | G2P2 | Giant CAA with stenosis and calcification |
NVD | None | 1 PROM (37wld) |
37 wks, healthy 38 wks, healthy |
CAA: coronary artery aneurysm; CABG: coronary artery bypass graft; NVD: normal vaginal delivery; PROM: premature rupture of membranes; PVC: premature ventricular contraction;
A review of women with a known or suspected history of KD residing outside of Japan revealed only four single-patient case reports.31-34 (Table 3) All had coronary artery aneurysms. Collectively these women gave birth to nine infants by vaginal delivery (8 infants) or C-section. One woman with an unknown history of KD suffered a myocardial infarction at 38 weeks gestation followed by vaginal delivery of a healthy infant. Coronary artery aneurysms were found and a history consistent with KD in childhood was elicited. Another woman with an unknown history of KD suffered a myocardial infarction at 20 weeks gestation, was found to have coronary artery aneurysms, and delivered a healthy infant at term. This woman delivered four subsequent infants vaginally and one infant by C-section without cardiovascular complications. The only obstetrical complication was pre-eclampsia in one woman followed by mild hypertension in her second pregnancy. Of the nine infants born to these mothers, all were healthy and and eight were delivered at term while one was delivered at 35 weeks to the mother with pre-eclampsia. The two subjects who suffered myocardial infarction during pregnancy highlight the potential catastrophic outcomes in patients with missed KD in childhood whose cardiac condition is not appropriately managed during pregnancy.
Two of the ten women in our series gave birth to infants who went on to develop KD in the first year of life. Both mothers were unaware of the genetic component to susceptibility to KD and were unfamiliar with the characteristic clinical signs of KD because they had no personal memory of their illness in childhood. This underscores the need for appropriate counseling of mothers with respect to the genetic risk of KD in their offspring. KD is thought to occur in genetically susceptible children following environmental exposure to an unknown agent that triggers the immunologic cascade that is recognized as acute KD. The genetic risk is determined by polymorphisms in a number of different biologic pathways and no risk prediction algorithm is currently available. 35,36 Japanese data suggest a two-fold increased risk of a history of KD among parents of children diagnosed with KD 37. The familial occurrence of KD is also well-documented in pedigrees from North America. 38 While there is no prenatal test to assess KD susceptibility, it is important for women to receive the information that susceptibility to KD has a genetic basis and that their offspring may be at increased risk.
Conclusion
There are three groups of women with a history of KD who may present to the obstetrician for management of pregnancy: women with normal echocardiograms during the acute illness, women with coronary artery abnormalities, and women with a history of KD whose cardiovascular status is unknown. Management during pregnancy should be directed collaboratively by maternal and fetal medicine and cardiology teams. For women with normal echocardiograms during acute KD, no screening or special considerations appear warranted and routine obstetric management is appropriate.9,10 For women contemplating pregnancy who have a history of KD associated with cardiovascular abnormalities, consultation with a cardiologist is advised. Late rupture of aneurysms does not occur and decisions regarding the safety of pregnancy should follow the same principles as for any other patient with cardiovascular compromise. A stress echocardiogram should be performed as part of pre-pregnancy screening or during the first trimester of pregnancy. Assessment of the coronary arteries prior to pregnancy should be performed with a CT angiogram or MR angiogram if performed after conception. Adjustment of medications must also be addressed including substitution of enoxaparin for warfarin and discontinuation of statins. Standard guidelines for management of women with cardiovascular compromise can be applied to this patient population. In the absence of congestive heart failure or severe ischemia, there is no indication for pregnancy termination solely on the basis of maternal cardiovascular disease due to KD. For women with a history of KD and unknown cardiovascular status, a stress echocardiogram and preconception CT calcium score may be useful to screen for coronary artery abnormalities. A positive calcium score should prompt further imaging by CT or MR angiogram. In summary, with appropriate surveillance and management the majority of women with a history of KD can successfully carry a pregnancy to term and have a normal labor and delivery.
4. Acknowledgements
None.
8. Funding
This work supported in part by grants from the National Heart, Lung, Blood Institute of the National Institutes of Health (HL U54 HL108460 to JCB and CS), the American Heart Association National Affiliate( to LBD), and the Gordon and Marilyn Macklin Foundation (to JCB and LBD).
Footnotes
5. Disclosure of Interests
No conflicts of interest to report.
7. Details of Ethics Approval
This study was first reviewed and approved by the Institutional Review Board at UCSD, Protocol # 090902 on 07/02/2009.
References
- 1.Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, et al. Kawasaki disease: A brief history. Pediatrics. 2000;106(2):E27. doi: 10.1542/peds.106.2.e27. [DOI] [PubMed] [Google Scholar]
- 2.Harnden A, Mayon-White R, Perera R, Yeates D, Goldacre M, Burgner D. Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J. 2009;28(1):21–24. doi: 10.1097/inf.0b013e3181812ca4. [DOI] [PubMed] [Google Scholar]
- 3.Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol. 2012;22(3):216–21. doi: 10.2188/jea.JE20110126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54(3):271–6. [PubMed] [Google Scholar]
- 5.Huang SK, Lin MT, Chen HC, Huang SC, Wu MH. Epidemiology of Kawasaki Disease: Prevalence from National Database and Future Trends Projection by System Dynamics Modeling. J Pediatr. 2013 doi: 10.1016/j.jpeds.2012.12.011. [DOI] [PubMed] [Google Scholar]
- 6.Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747–71. doi: 10.1161/01.CIR.0000145143.19711.78. [DOI] [PubMed] [Google Scholar]
- 7.Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379–85. doi: 10.1161/01.cir.94.6.1379. [DOI] [PubMed] [Google Scholar]
- 8.Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS ONE. 2012;7(6):e38998. doi: 10.1371/journal.pone.0038998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gordon JB, Kahn AM, Burns JC. When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol. 2009;54(21):1911–20. doi: 10.1016/j.jacc.2009.04.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Daniels LB, Gordon JB, Burns JC. Kawasaki disease: late cardiovascular sequelae. Current opinion in cardiology. 2012;27(6):572–7. doi: 10.1097/HCO.0b013e3283588f06. [DOI] [PubMed] [Google Scholar]
- 11.Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol. 1996;28(1):253–7. doi: 10.1016/0735-1097(96)00099-x. [DOI] [PubMed] [Google Scholar]
- 12.Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. The New England journal of medicine. 1991;324(23):1633–9. doi: 10.1056/NEJM199106063242305. [DOI] [PubMed] [Google Scholar]
- 13.Kahn AM, Budoff MJ, Daniels LB, Jimenez-Fernandez S, Cox AS, Gordon JB, et al. Calcium scoring in patients with a history of Kawasaki disease. JACC Cardiovasc Imaging. 2012;5(3):264–72. doi: 10.1016/j.jcmg.2011.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tsuda E, Abe T, Tamaki W. Acute coronary syndrome in adult patients with coronary artery lesions caused by Kawasaki disease: review of case reports. Cardiol Young. 2011;21(1):74–82. doi: 10.1017/S1047951110001502. [DOI] [PubMed] [Google Scholar]
- 15.McCrindle BW. Kawasaki disease: a childhood disease with important consequences into adulthood. Circulation. 2009;120(1):6–8. doi: 10.1161/CIRCULATIONAHA.109.874800. [DOI] [PubMed] [Google Scholar]
- 16.Tsuda E, Matsuo M, Naito H, Noguchi T, Nonogi H, Echigo S. Clinical features in adults with coronary arterial lesions caused by presumed Kawasaki disease. Cardiol Young. 2007;17(1):84–9. doi: 10.1017/S1047951107000169. [DOI] [PubMed] [Google Scholar]
- 17.Senzaki H. Long-term outcome of Kawasaki disease. Circulation. 2008;118(25):2763–72. doi: 10.1161/CIRCULATIONAHA.107.749515. [DOI] [PubMed] [Google Scholar]
- 18.Suda K, Iemura M, Nishiono H, Teramachi Y, Koteda Y, Kishimoto S, et al. Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation. 2011;123(17):1836–42. doi: 10.1161/CIRCULATIONAHA.110.978213. [DOI] [PubMed] [Google Scholar]
- 19.Samada K, Shiraishi H, Sato A, Momoi MY. Grown-up Kawasaki disease patients who have giant coronary aneurysms. World J Pediatr. 2010;6(1):38–42. doi: 10.1007/s12519-010-0004-7. [DOI] [PubMed] [Google Scholar]
- 20.Alam S, Sakura S, Kosaka Y. Anaesthetic management for caesarean section in a patient with Kawasaki disease. Can J Anaesth. 1995;42(11):1024–6. doi: 10.1007/BF03011076. [DOI] [PubMed] [Google Scholar]
- 21.Kobara Successful vaginal deliveries in a woman with Kawasaki disease-related cardiovascular sequelae. Jpn J Obstet Gynecol Neonatal Hematol. 2011;20(2):49–54. [Google Scholar]
- 22.Kurioka Pregnancy and delivery in a woman with a history of Kawasaki Disease. Nippon Sanka Fujinka gakkai Cyugoku Shikoku Goudou Chihoubukai zasshi. 1996;44(2):158–61. [Google Scholar]
- 23.Arakawa K, Akita T, Nishizawa K, Kurita A, Nakamura H, Yoshida T, et al. Anticoagulant therapy during successful pregnancy and delivery in a Kawasaki disease patient with coronary aneurysm--a case report. Jpn. Circ. J. 1997;61(2):197–200. doi: 10.1253/jcj.61.197. [DOI] [PubMed] [Google Scholar]
- 24.Tsuda H. Case report of pregnancy and delivery in a women with a history of Kawasaki disease and giant aneurysms. Rinsho fujinka sanka. 1997;51(1):99–101. [Google Scholar]
- 25.Iino Case report of pregnancy in a woman with a history of Kawasaki disease. Sanka To Fujinka. 1997;64(6):867–72. [Google Scholar]
- 26.Hayakawa H, Katoh T. Successful pregnancy after coronary artery bypass grafting for Kawasaki disease. Acta paediatrica Japonica; Overseas edition. 1998;40(3):275–7. doi: 10.1111/j.1442-200x.1998.tb01927.x. [DOI] [PubMed] [Google Scholar]
- 27.Tsuda E. Case report of pregnancy in a woman with history of Kawasaki disease and coronary artery stenosis. Progress in Medicine. 1999;19(7):1626–30. [Google Scholar]
- 28.Tsuda E, Kawamata K, Neki R, Echigo S, Chiba Y. Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan. Cardiol Young. 2006;16(2):173–8. doi: 10.1017/S1047951106000126. [DOI] [PubMed] [Google Scholar]
- 29.Tsuda E, Ishihara Y, Kawamata K, Tsukano S, Negi R, Echigo S, et al. Pregnancy and delivery in patients with coronary artery lesions caused by Kawasaki disease. Heart (British Cardiac Society) 2005;91(11):1481–2. doi: 10.1136/hrt.2004.058842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Tatsumi Four cases of pregnancies in women with history of Kawasaki disease and coronary artery aneurysms. Nippon Shoni Junkanki Gakkai. 2001;17(1):52–59. [Google Scholar]
- 31.Nolan TE, Savage RW. Peripartum myocardial infarction from presumed Kawasaki's disease. South. Med. J. 1990;83(11):1360–1. doi: 10.1097/00007611-199011000-00038. [DOI] [PubMed] [Google Scholar]
- 32.Shear R, Leduc L. Successful pregnancy following Kawasaki disease. Obstetrics and gynecology. 1999;94(5):841. doi: 10.1016/s0029-7844(99)00348-8. Pt 2. [DOI] [PubMed] [Google Scholar]
- 33.Hibbard JU, Fajardo JE, Briller J. Kawasaki disease with coronary artery sequelae. Obstetrics and gynecology. 2007;109(2):517–9. doi: 10.1097/01.AOG.0000228963.21281.b8. Pt2. [DOI] [PubMed] [Google Scholar]
- 34.McAndrew P, Hughes D, Adams P. Pregnancy and Kawasaki disease. International journal of obstetric anesthesia. 2000;9(4):279–81. doi: 10.1054/ijoa.2000.0723. [DOI] [PubMed] [Google Scholar]
- 35.Hata A, Onouchi Y. Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine. J Hum Genet. 2009;54(2):67–73. doi: 10.1038/jhg.2008.9. [DOI] [PubMed] [Google Scholar]
- 36.Onouchi Y. Molecular genetics of Kawasaki disease. Pediatr Res. 2009;65(5):46R–54R. doi: 10.1203/PDR.0b013e31819dba60. Pt 2. [DOI] [PubMed] [Google Scholar]
- 37.Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease in parents and children. Acta Paediatr. 2003;92(6):694–7. doi: 10.1080/08035320310002768. [DOI] [PubMed] [Google Scholar]
- 38.Dergun M, Kao A, Hauger SB, Newburger JW, Burns JC. Familial occurrence of Kawasaki syndrome in North America. Arch Pediatr Adolesc Med. 2005;159(9):876–81. doi: 10.1001/archpedi.159.9.876. [DOI] [PMC free article] [PubMed] [Google Scholar]

